Skip to content

IRWD

Ironwood Pharmaceuticals, Inc.

NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US

$4.26
−0.70%
Ask drillr
0
Insider buys (3m)
2
Insider sells (3m)
-$658.5K
Net value (3m)
+28.5%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Jul 22, 2026Silber Jeffrey · officer: SVP, CMO, Head-Res&DrugA-Award137,036$0.00
Jul 9, 2026Silver Ronald · officer: PFO & PAOSale127,890$4.52
Jun 17, 2026McHugh Julie · directorA-Award63,481$0.00
Jun 17, 2026DENNER ALEXANDER J · directorA-Award63,481$0.00
Jun 17, 2026Shepard Jay · directorA-Award63,481$0.00
Jun 17, 2026DENNER ALEXANDER J · directorA-Award4,065$0.00
Jun 17, 2026Kessler Marla L · directorA-Award63,481$0.00
Jun 17, 2026Moukheibir Catherine · directorA-Award63,481$0.00
Jun 17, 2026Currie Mark G · directorA-Award63,481$0.00
Jun 17, 2026McHugh Julie · directorSale21,571$3.73
Jun 17, 2026Duane Jon R · directorA-Award63,481$0.00
May 21, 2026Silver Ronald · officer: PFO & PAOA-Award25,000$0.00
Mar 17, 2026DENNER ALEXANDER J · directorSale5,800$3.31
Mar 17, 2026DENNER ALEXANDER J · directorSale6,725,000$3.05
Mar 17, 2026DENNER ALEXANDER J · directorA-Award4,451$0.00
Mar 12, 2026Shetzline Michael · officer: SVP, CMO, Head-Res&DrugA-Award136,612$0.00
Mar 12, 2026Silver Ronald · officer: Principal Accounting OfficerA-Award163,934$0.00
Mar 12, 2026MCCOURT Thomas A · director, officer: Chief Executive OfficerA-Award409,836$0.00
Mar 12, 2026Martini Gregory S. · officer: Chief Financial OfficerA-Award136,612$0.00
Mar 12, 2026Gaskins Tammi L · officer: Chief Commercial OfficerA-Award136,612$0.00
Mar 12, 2026John Minardo · officer: Chief Legal OfficerA-Award136,612$0.00
Feb 25, 2026Silver Ronald · officer: Principal Accounting OfficerSale11,552$3.81
Feb 25, 2026Gaskins Tammi L · officer: Chief Commercial OfficerSale10,287$3.81
Feb 25, 2026Gaskins Tammi L · officer: Chief Commercial OfficerSale11,239$3.66
Feb 25, 2026Silver Ronald · officer: Principal Accounting OfficerSale12,621$3.66
Feb 25, 2026Martini Gregory S. · officer: Chief Financial OfficerSale10,487$3.81
Feb 25, 2026Shetzline Michael · officer: SVP, CMO, Head-Res&DrugSale15,570$3.81
Feb 25, 2026Martini Gregory S. · officer: Chief Financial OfficerSale11,457$3.66
Feb 25, 2026MCCOURT Thomas A · director, officer: Chief Executive OfficerSale94,757$3.81
Feb 25, 2026John Minardo · officer: Chief Legal OfficerSale19,053$3.66
Institutional positioning

13F filings over the trailing two quarters

New 79Increased 160Reduced 145Sold out 36
FilerActionSharesFiled
BlackRock, Inc.Increased17,788,557Aug 7, 2026
ARMISTICE CAPITAL, LLCReduced15,028,000May 15, 2026
ARMISTICE CAPITAL, LLCReduced13,932,000Aug 14, 2026
BLACKROCK, INC.Increased13,362,930May 13, 2026
UBS GROUP AGIncreased12,133,545May 5, 2026
Sarissa Capital Management LPUnchanged9,188,635Aug 14, 2026
SARISSA CAPITAL MANAGEMENT LPReduced9,188,635May 15, 2026
STATE STREET CORPIncreased8,809,601Aug 7, 2026
BANK OF AMERICA CORP /DE/Increased8,683,803Aug 14, 2026
BANK OF AMERICA CORP /DE/Reduced8,682,907May 18, 2026
RENAISSANCE TECHNOLOGIES LLCReduced8,061,073May 14, 2026
RENAISSANCE TECHNOLOGIES LLCReduced7,993,226Aug 13, 2026
AQR CAPITAL MANAGEMENT LLCIncreased7,535,080May 15, 2026
STATE STREET CORPIncreased7,456,944May 15, 2026
VANGUARD PORTFOLIO MANAGEMENT LLCNew Position6,682,037May 8, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Jul 22, 2026